Toggle navigation
Home
Search
Services
Blog
Contact
About
Temozolomide Resistance in CNS Tumors
Friedman, Henry S.
Duke University, Durham, NC, United States
Search 102 grants from Henry Friedman
Search grants from Duke University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
Mechanisms of Chemotherapy Induced Cognitive Defects
Multidrug Resistance Mediated by P-glycoprotein
Hope Partnership (Health Observances & Public Education)
Peripheral and Central Mechanisms of Nociception
Recently added grants:
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia
Vascular Targeting of Nanocarriers for RNA
Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies
Dendritic Mechanisms Underlying Behaviorally-Relevant Activity in a Descending Auditory Pathway
EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA081651-02
Application #
6174372
Study Section
Special Emphasis Panel (ZRG1-ET-1 (04))
Program Officer
Wu, Roy S
Project Start
1999-04-01
Project End
2001-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
2
Fiscal Year
2000
Total Cost
$154,000
Indirect Cost
Institution
Name
Duke University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Related projects
NIH 2000
R21 CA
Temozolomide Resistance in CNS Tumors
Friedman, Henry S. / Duke University
$154,000
NIH 1999
R21 CA
Temozolomide Resistance in CNS Tumors
Friedman, Henry S. / Duke University
Comments
Be the first to comment on Henry Friedman's grant